Cargando…

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus

Detalles Bibliográficos
Autores principales:	Rashid, Hanan, Poelhekken, Mila, Meijer, Joost M., Bolling, Maria C., Horváth, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892131/ https://www.ncbi.nlm.nih.gov/pubmed/35252887 http://dx.doi.org/10.1016/j.jdin.2022.01.004

Ejemplares similares

Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid
por: Rashid, H., et al.
Publicado: (2021)

Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical cases
por: Zaheri, Farhat, et al.
Publicado: (2022)

Efficacy of rituximab in pediatric pemphigus: A literature review
por: Patel, Meera H., et al.
Publicado: (2021)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Rituximab in Pemphigus: Road Covered and Challenges Ahead
por: Vinay, Keshavamurthy, et al.
Publicado: (2018)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
por: Kanokrungsee, Silada, et al.
Publicado: (2021)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
por: Chotaliya, Kiran K., et al.
Publicado: (2015)

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
por: Fenizia, Claudio, et al.
Publicado: (2023)

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
por: Song, Ahreum, et al.
Publicado: (2022)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab therapy in pemphigus and other autoantibody-mediated diseases
por: Ran, Nina A., et al.
Publicado: (2017)

Follow-up Data of Rituximab as Adjuvant Therapy in Pemphigus
por: Khopkar, Uday S, et al.
Publicado: (2017)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
por: BAUM, Sharon, et al.
Publicado: (2020)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm
por: Rashid, Hanan, et al.
Publicado: (2019)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

The impact of anaphylaxis on the quality of life and mental health of adults
por: Knibb, Rebecca C., et al.
Publicado: (2022)

Pemphigus Contagiosus
Publicado: (1905)

Quality of Life Assessment in Korean Patients with Pemphigus
por: Sung, Jae Yong, et al.
Publicado: (2015)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab
por: Font, Guillaume, et al.
Publicado: (2022)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
por: Dehghanimahmoudabadi, Azin, et al.
Publicado: (2022)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Biologic therapy-induced pemphigus
por: Hayashida, Marina Zoega, et al.
Publicado: (2017)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
por: Agarwal, Ashwin, et al.
Publicado: (2018)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Fortuna, Giulio, et al.
Publicado: (2021)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Mycobacterium tuberculosis and pemphigus vulgaris
por: Osipowicz, Katarzyna, et al.
Publicado: (2018)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
por: Corral, Isabela Soubhia, et al.
Publicado: (2013)

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab
por: Ito, Yuta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6aklmt2cdvl16o4137trcblo9q